Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on plasminogen activator inhibitor-1

D Vaughan1

  • 1Cardiology Division, Vanderbilt University, Nashville, TN 37232, USA. doug.vaughan@mcmail.vanderbilt.edu

The Canadian Journal of Cardiology
|August 26, 1998
PubMed
Summary

Plasminogen activator inhibitor-1 (PAI-1) regulates blood clot breakdown. This review examines PAI-1 gene variations and how glucose affects its expression in vascular disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lean body weight local anaesthesia topicalisation charts for awake tracheal intubation.

Anaesthesia·2022
Same author

Growth and Cyclin-E Expression in the Stony Coral Species <i>Orbicella faveolata</i> Post-Microfragmentation.

The Biological bulletin·2022
Same author

Chemical Nature of Malaria.

The Dental register·2021
Same author

Chemical Affinity.

The Dental register·2021
Same author

Difficult Airway Society guidelines for awake tracheal intubation (ATI) in adults.

Anaesthesia·2019
Same author

Identifying hospital-acquired infections using retrospective record review from the Irish National Adverse Events Study (INAES) and European point prevalence survey case definitions.

The Journal of hospital infection·2018

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Vascular Biology

Background:

  • Plasminogen activator inhibitor-1 (PAI-1) is a key regulator of fibrinolysis, produced by endothelial cells.
  • PAI-1 levels influence the rate and extent of blood clot dissolution.
  • Vascular disease pathogenesis is linked to altered fibrinolytic activity.

Purpose of the Study:

  • To review recent findings on plasminogen activator inhibitor-1 (PAI-1) gene polymorphism.
  • To explore the potential role of glucose in regulating PAI-1 expression.
  • To discuss the implications for vascular disease.

Main Methods:

  • Literature review of recent scientific data.
  • Analysis of studies on PAI-1 gene polymorphism.
  • Examination of research on glucose's effect on PAI-1 expression.

Main Results:

  • PAI-1 gene polymorphisms may influence PAI-1 levels and fibrinolytic function.
  • Glucose appears to play a significant role in modulating PAI-1 expression.
  • These factors are relevant to the development and progression of vascular diseases.

Conclusions:

  • Understanding PAI-1 gene variations and glucose regulation is crucial for comprehending vascular disease.
  • Further research into PAI-1's role in vascular health is warranted.

Related Experiment Videos